A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Global health financing examines how low- and middle-income countries (LMICs) fund healthcare, the role of international development assistance, and the path toward universal health coverage. LMICs face a fundamental constraint: limited government revenue (often 10-20% of GDP, compared to 30-50% in high-income countries) must cover healthcare alongside education, infrastructure, and security. Out-of-pocket spending dominates in many LMICs — 40-60% of total health expenditure in some countries — causing catastrophic health expenditure (pushing 100+ million people into poverty annually). Development assistance for health (DAH) from bilateral donors, multilateral organizations (WHO, World Bank), and global health initiatives (GAVI, Global Fund) supplements domestic financing but creates its own distortions: vertical program focus, donor dependency, fragmentation, and misalignment with national priorities.
High-income countries spend 5-12% of GDP on health, financed primarily through taxation and mandatory insurance contributions, with out-of-pocket spending typically below 20% of total health expenditure. Low- and middle-income countries face a fundamentally different financing landscape: lower GDP, lower government revenue as a share of GDP, weaker tax administration, larger informal economies that evade taxation, and competing demands for limited public resources. The result is that many LMICs spend less than $100 per capita on health (compared to $5,000-12,000 in high-income countries), and a large share comes from out-of-pocket payments.
Catastrophic health expenditure — defined by WHO as out-of-pocket health spending exceeding 10-25% of household income — is the most visible consequence of inadequate health financing. When a family member is hospitalized, the household may sell assets, withdraw children from school, or borrow at predatory rates. The World Bank estimates that 100+ million people are pushed into extreme poverty annually by health costs. This is not just a health problem — it is a development trap, because impoverished households cannot invest in education, nutrition, or productive assets.
Development assistance for health peaked at approximately $40 billion annually and targets specific diseases (HIV/AIDS, malaria, tuberculosis), maternal/child health, and vaccination. Organizations like GAVI (vaccines), the Global Fund (AIDS, TB, malaria), and PEPFAR (HIV) have achieved remarkable results: HIV treatment coverage expanded from under 1 million to over 25 million people. But DAH represents a small fraction of total health spending in most LMICs and creates sustainability concerns. When external funding declines, countries that built HIV programs on donor money face impossible choices about maintaining services from domestic revenue.
The path toward universal health coverage in LMICs requires expanding domestic fiscal space (increasing tax revenue), reducing reliance on out-of-pocket payments (through prepayment mechanisms — social insurance or tax-funded coverage), improving efficiency (reducing waste, corruption, and fragmentation), and strategically deploying external assistance to build sustainable systems rather than parallel vertical programs. Countries like Thailand, Rwanda, and Ghana have made significant progress by combining political commitment with pragmatic financing reforms — demonstrating that universal coverage is achievable even at relatively low income levels.